| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 0 | 112.756 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 705 | 40.236 | 138.853 | 3.461 |
| Total Expenses - EUR | - | - | - | - | - | - | 7.968 | 49.420 | 213.593 | 6.841 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -7.263 | -9.184 | -74.741 | -3.380 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -7.263 | -9.184 | -74.741 | -3.380 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biolab Diagnostic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 131.729 | 1.576.274 | 1.200.534 | 1.363.214 |
| Current Assets | - | - | - | - | - | - | 19.434 | 80.615 | 202.597 | 202.075 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 14.880 | 71.863 | 200.284 | 199.774 |
| Cash | - | - | - | - | - | - | 4.554 | 8.752 | 2.313 | 2.300 |
| Shareholders Funds | - | - | - | - | - | - | -7.183 | -16.389 | -91.080 | 50.388 |
| Social Capital | - | - | - | - | - | - | 81 | 81 | 81 | 99.994 |
| Debts | - | - | - | - | - | - | 158.345 | 1.673.279 | 1.494.211 | 1.514.901 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6811 - 6811" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Biolab Diagnostic S.r.l.